1. Home
  2. FLGT vs IPI Comparison

FLGT vs IPI Comparison

Compare FLGT & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • IPI
  • Stock Information
  • Founded
  • FLGT 2011
  • IPI 2000
  • Country
  • FLGT United States
  • IPI United States
  • Employees
  • FLGT N/A
  • IPI N/A
  • Industry
  • FLGT Medical Specialities
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • FLGT Health Care
  • IPI Industrials
  • Exchange
  • FLGT Nasdaq
  • IPI Nasdaq
  • Market Cap
  • FLGT 587.3M
  • IPI 470.9M
  • IPO Year
  • FLGT 2016
  • IPI 2008
  • Fundamental
  • Price
  • FLGT $18.36
  • IPI $33.07
  • Analyst Decision
  • FLGT Buy
  • IPI Strong Sell
  • Analyst Count
  • FLGT 2
  • IPI 1
  • Target Price
  • FLGT $23.00
  • IPI $24.00
  • AVG Volume (30 Days)
  • FLGT 310.0K
  • IPI 135.0K
  • Earning Date
  • FLGT 08-01-2025
  • IPI 08-06-2025
  • Dividend Yield
  • FLGT N/A
  • IPI N/A
  • EPS Growth
  • FLGT N/A
  • IPI N/A
  • EPS
  • FLGT N/A
  • IPI N/A
  • Revenue
  • FLGT $303,223,000.00
  • IPI $217,865,000.00
  • Revenue This Year
  • FLGT $11.79
  • IPI $11.06
  • Revenue Next Year
  • FLGT $10.45
  • IPI $0.74
  • P/E Ratio
  • FLGT N/A
  • IPI N/A
  • Revenue Growth
  • FLGT 4.31
  • IPI N/A
  • 52 Week Low
  • FLGT $14.57
  • IPI $20.75
  • 52 Week High
  • FLGT $25.00
  • IPI $39.01
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 46.81
  • IPI 38.86
  • Support Level
  • FLGT $16.98
  • IPI $31.50
  • Resistance Level
  • FLGT $19.51
  • IPI $37.38
  • Average True Range (ATR)
  • FLGT 0.69
  • IPI 1.45
  • MACD
  • FLGT 0.04
  • IPI -0.23
  • Stochastic Oscillator
  • FLGT 54.55
  • IPI 24.57

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: